
Quarterly Result29 May 2026, 10:11 pm
Asston Pharma Audited Results for FY26
AI Summary
Asston Pharmaceuticals Ltd has announced its audited financial results for the year ended March 31, 2026. The Board of Directors approved the financial statements and results during a meeting held on May 29, 2026. The audit report, conducted by Panchal S K & Associates, provides an opinion that the financial results present a true and fair view in accordance with regulatory requirements and accounting standards.
Key Highlights
- Asston Pharma's board approved audited financial results for FY26.
- Meeting held on May 29, 2026, via video conferencing.
- Audited financial statements comply with SEBI regulations.
- Panchal S K & Associates issued an independent auditor's report.
- Financial results reflect a true and fair view for FY26.
Price Impact
More from APL